paclitaxel (Suzhou Leina Drug Development)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepaclitaxel (Suzhou Leina Drug Development)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule stabilizer
TargetsUpdating
Therapy Area/IndicationsMetastatic breast cancerSolid tumoursCarcinoma, Non-Small-Cell Lung +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Leina Pharmacy R&D Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Leina Pharmacy R&D Co Ltd
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerSolid tumoursCarcinoma, Non-Small-Cell Lung +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A